Results 201 to 210 of about 1,957,522 (351)
Pancreatic ductal adenocarcinoma (PDAC) is a disease with very poor prognosis due to therapeutic limitations. We investigated the antitumor effects of cystatin A (CSTA) in PDAC murine models. We are first to confirm that CSTA enhances T helper type 1‐mediated antitumor effects through promotion of dendritic cells and M1 macrophage activity. CSTA can be
Alessandro Nasti+8 more
wiley +1 more source
Correction: Metabolomic heterogeneity of ageing with ethnic diversity: a step closer to healthy ageing. [PDF]
Trivedi D+5 more
europepmc +1 more source
Cell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer
mFast‐SeqS‐based genome‐wide aneuploidy scores are concordant with aneuploidy scores obtained by whole genome sequencing from tumor tissue and can predict response to ARSI treatment at baseline and, at an early time point, to ARSI and taxanes. This assay can be easily performed at low cost and requires little input of cfDNA. Cell‐free circulating tumor
Khrystany T. Isebia+17 more
wiley +1 more source
Studies in the biochemistry of micro-organisms [PDF]
Percival Walter Clutterbuck+3 more
openalex +3 more sources
Corrigendum: Antioxidant, Anti-Alzheimer's, anticancer, and cytotoxic properties of peanut oil: <i>in vitro</i>, <i>in silico</i>, and GC-MS analysis. [PDF]
Djeghim H+6 more
europepmc +1 more source
Prostate cancer is a leading malignancy with significant clinical heterogeneity in men. An 11‐gene signature derived from dysregulated epithelial cell markers effectively predicted biochemical recurrence‐free survival in patients who underwent radical surgery or radiotherapy.
Zhuofan Mou, Lorna W. Harries
wiley +1 more source
Extended release huperzine for the treatment of idiopathic epilepsy in dogs - a Case Report. [PDF]
Grant KL, Long SN.
europepmc +1 more source